Hyderabad: Research by ReaGene Innovations Private Limited, a startup incubated at the ASPIRE-BioNEST, and INDRAS Private Limited suggests that an anti-diabetic drug Ertugliflozin, can be repurposed to treat Covid-19. According to the findings, the repurposed drug binds effectively to the receptor binding domain of the spike protein of Covid-19 and also displayed significant anti-inflammatory and […]
The first result offering a safe, ready-to-use and cost-effective solution for Covid-19 treatment, Ertugliflozin is an FDA approved drug for type-2 diabetes.